Skip to main content
Pradnya Patil, MD, Oncology, Cleveland, OH

PradnyaDinkarPatilMDFACP

Oncology Cleveland, OH

Thoracic Cancer

Associate Staff, Taussig Cancer Institute, Cleveland Clinic Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Dr. Patil is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Patil's full profile

Already have an account?

  • Office

    9500 Euclid Ave
    Cleveland, OH 44195
    Phone+1 502-526-6835
    Fax+1 215-456-7926

Education & Training

  • Albert Einstein Healthcare Network
    Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2010 - 2013
  • Seth G.S. Medical College
    Seth G.S. Medical CollegeClass of 2008

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2023 - 2025
  • OH State Medical License
    OH State Medical License 2013 - 2024
  • PA State Medical License
    PA State Medical License 2010 - 2013
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Impact of invasive regional lymph node examination (IRLNE) and time to radiation on overall survival for patients with stage I NSCLC treated with SBRT- a NCDB analysis. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Incidence and patterns of immune related adverse events (irAEs) during chemoimmunotherapy (ChemoIO) in patients with advanced nonsquamous NSCLC. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Neutrophil to Lymphocyte Ratio Influences Impact of Steroids on Efficacy of Immune Checkpoint Inhibitors in Lung Cancer Brain Metastases
    Neutrophil to Lymphocyte Ratio Influences Impact of Steroids on Efficacy of Immune Checkpoint Inhibitors in Lung Cancer Brain MetastasesApril 5th, 2021
  • Artificial Intelligence Identifies Lung Cancer Patients at Risk of Harm Caused by Immunotherapy
    Artificial Intelligence Identifies Lung Cancer Patients at Risk of Harm Caused by ImmunotherapyFebruary 9th, 2021
  • AI Technology Can Help Prevent Adverse Effect of Immunotherapy in Certain Lung Cancer Patients
    AI Technology Can Help Prevent Adverse Effect of Immunotherapy in Certain Lung Cancer PatientsFebruary 5th, 2021
  • Join now to see all

Professional Memberships